Suppression of STN1 enhances the cytotoxicity of chemotherapeutic agents in cancer cells by elevating DNA damage
Authors:
Open Access
- 2 June 2016
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 12 (2) , 800-808
Abstract
DNA damage-inducing agents are among the most effective treatment regimens in clinical chemotherapy. However, drug resistance and severe side effects caused by these agents greatly limit their efficacy. Sensitizing malignant cells to chemotherapeutic agents has long been a goal of chemotherapy. In the present study, suppression of STN1, a gene important for safeguarding genome stability, potentiated the anticancer effect of chemotherapeutic agents in tumor cells. Using multiple cancer cells from a variety of origins, it was observed that downregulation of STN1 resulted in a significant decrease in the half maximal inhibitory concentration values of several conventional anticancer agents. When cells are treated with anticancer agents, STN1 suppression leads to a decline in colony formation and diminished anchorage-independent growth. Furthermore, it was additionally observed that STN1 knockdown augmented the levels of DNA damage caused by damage‑inducing agents. The present study concluded that suppression of STN1 enhances the cytotoxicity of damage‑inducing chemotherapeutic agents by increasing DNA damage in cancer cells.Keywords
This publication has 42 references indexed in Scilit:
- Human CST Has Independent Functions during Telomere Duplex Replication and C-Strand Fill-InCell Reports, 2012
- CTC1 deletion results in defective telomere replication, leading to catastrophic telomere loss and stem cell exhaustionThe EMBO Journal, 2012
- Antiapoptotic effects of roscovitine on camptothecin-induced DNA damage in neuroblastoma cellsApoptosis, 2011
- Telomere-Based Cancer TreatmentClinical Journal of Oncology Nursing, 2010
- Molecular steps of G‐overhang generation at human telomeres and its function in chromosome end protectionThe EMBO Journal, 2010
- Chemosensitization of cancer cells by siRNA using targeted nanogel deliveryBMC Cancer, 2010
- OB Fold-containing Protein 1 (OBFC1), a Human Homolog of Yeast Stn1, Associates with TPP1 and Is Implicated in Telomere Length RegulationJournal of Biological Chemistry, 2009
- A DNA Polymerase-α·Primase Cofactor with Homology to Replication Protein A-32 Regulates DNA Replication in Mammalian CellsJournal of Biological Chemistry, 2009
- Targeting telomeres and telomeraseBiochimie, 2008
- Telomere, telomerase and agingMechanisms of Ageing and Development, 2008